Published online before print March 10, 2005, doi: 10.1161/01.RES.0000162101.76263.8c
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 American Heart Association, Inc.
Clinical Research |
A Novel Form of Short QT Syndrome (SQT3) Is Caused by a Mutation in the KCNJ2 Gene
From the Molecular Cardiology (S.G.P., I.R., E.R., C.N., M.R.d.B.), IRCCS Fondazione Maugeri, Pavia, Italy; University of Pavia (S.G.P.), Pavia, Italy; Pediatric Cardiology Unit (G.B.), Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy; Pediatric Arrhythmias Center (M.S.-B.), Istituto Auxologico Italiano IRCCS, Milan, Italy; and the Department of Pharmacology and Institute for Cardiovascular Research (S.V.P., O.B., A.D., J.A., S.G., J.J.), SUNY Upstate Medical University, Syracuse, NY.
Correspondence to Silvia G. Priori, MD, PhD, Molecular Cardiology, Maugeri Foundation, University of Pavia, Via Ferrata 8, 27100, Pavia, Italy. E-mail spriori{at}fsm.it
Short QT syndrome (SQTS) leads to an abbreviated QTc interval and predisposes patients to life-threatening arrhythmias. To date, two forms of the disease have been identified: SQT1, caused by a gain of function substitution in the HERG (IKr) channel, and SQT2, caused by a gain of function substitution in the KvLQT1 (IKs) channel. Here we identify a new variant, "SQT3", which has a unique ECG phenotype characterized by asymmetrical T waves, and a defect in the gene coding for the inwardly rectifying Kir2.1 (IK1) channel. The affected members of a single family had a G514A substitution in the KCNJ2 gene that resulted in a change from aspartic acid to asparagine at position 172 (D172N). Whole-cell patch-clamp studies of the heterologously expressed human D172N channel demonstrated a larger outward IK1 than the wild-type (P<0.05) at potentials between –75 mV and –45 mV, with the peak current being shifted in the former with respect to the latter (WT, –75 mV; D172N, –65 mV). Coexpression of WT and mutant channels to mimic the heterozygous condition of the proband yielded an outward current that was intermediate between WT and D172N. In computer simulations using a human ventricular myocyte model the increased outward IK1 greatly accelerated the final phase of repolarization, and shortened the action potential duration. Hence, unlike the known mutations in the two other SQTS forms (N588K in HERG and V307L in KvLQT1), simulations using the D172N and WT/D172N mutations fully accounted for the ECG phenotype of tall and asymmetrically shaped T waves. Although we were unable to test for inducibility of arrhythmia susceptibility due to lack of patients’ consent, our computer simulations predict a steeper steady-state restitution curve for the D172N and WT/D172N mutation, compared with WT or to HERG or KvLQT1 mutations, which may predispose SQT3 patients to a greater risk of reentrant arrhythmias.
Key Words: genetics • arrhythmias • ion channels • cellular electrophysiology
Related Article:
Circ. Res. 2005 96: 703-704.
This article has been cited by other articles:
 |
|
 |
|
  A. L. Vega, D. J. Tester, M. J. Ackerman, and J. C. Makielski Protein Kinase A-Dependent Biophysical Phenotype for V227F-KCNJ2 Mutation in Catecholaminergic Polymorphic Ventricular Tachycardia Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 540 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Vikstrom, R. Vaidyanathan, S. Levinsohn, R. P. O'Connell, Y. Qian, M. Crye, J. H. Mills, and J. M. B. Anumonwo SAP97 regulates Kir2.3 channels by multiple mechanisms Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1387 - H1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zaks-Makhina, H. Li, A. Grishin, V. Salvador-Recatala, and E. S. Levitan Specific and Slow Inhibition of the Kir2.1 K+ Channel by Gambogic Acid J. Biol. Chem., June 5, 2009; 284(23): 15432 - 15438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Sekar, E. Kizana, H. C. Cho, J. M. Molitoris, G. G. Hesketh, B. P. Eaton, E. Marban, and L. Tung IK1 Heterogeneity Affects Genesis and Stability of Spiral Waves in Cardiac Myocyte Monolayers Circ. Res., February 13, 2009; 104(3): 355 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth CHAPTER 9 Genetics of Cardiovascular Diseases ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Behr, C. Dalageorgou, M. Christiansen, P. Syrris, S. Hughes, M. T. Tome Esteban, E. Rowland, S. Jeffery, and W. J. McKenna Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families Eur. Heart J., July 1, 2008; 29(13): 1670 - 1680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Rodriguez-Menchaca, R. A. Navarro-Polanco, T. Ferrer-Villada, J. Rupp, F. B. Sachse, M. Tristani-Firouzi, and J. A. Sanchez-Chapula The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel PNAS, January 29, 2008; 105(4): 1364 - 1368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Sekar, E. Kizana, R. R. Smith, A. S. Barth, Y. Zhang, E. Marban, and L. Tung Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2757 - H2770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ishihara and D.-H. Yan Low-affinity spermine block mediating outward currents through Kir2.1 and Kir2.2 inward rectifier potassium channels J. Physiol., September 15, 2007; 583(3): 891 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF]
|
|
|
|
|
|
M. N. Viswanathan and R. L. Page Short QT: When Does It Matter? Circulation, August 14, 2007; 116(7): 686 - 688. [Full Text] [PDF]
|
|
|
|
|
|
D. Fatkin, R. Otway, and J. I. Vandenberg Genes and Atrial Fibrillation: A New Look at an Old Problem Circulation, August 14, 2007; 116(7): 782 - 792. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bendahhou, E. Fournier, S. Gallet, D. Menard, M.-M. Larroque, and J. Barhanin Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred Hum. Mol. Genet., April 15, 2007; 16(8): 900 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Antzelevitch, G. D. Pollevick, J. M. Cordeiro, O. Casis, M. C. Sanguinetti, Y. Aizawa, A. Guerchicoff, R. Pfeiffer, A. Oliva, B. Wollnik, et al. Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death Circulation, January 30, 2007; 115(4): 442 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Noujaim, S. V. Pandit, O. Berenfeld, K. Vikstrom, M. Cerrone, S. Mironov, M. Zugermayr, A. N. Lopatin, and J. Jalife Up-regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotors J. Physiol., January 1, 2007; 578(1): 315 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Giustetto, F. Di Monte, C. Wolpert, M. Borggrefe, R. Schimpf, P. Sbragia, G. Leone, P. Maury, O. Anttonen, M. Haissaguerre, et al. Short QT syndrome: clinical findings and diagnostic-therapeutic implications Eur. Heart J., October 2, 2006; 27(20): 2440 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori and C. Napolitano Role of Genetic Analyses in Cardiology: Part I: Mendelian Diseases: Cardiac Channelopathies Circulation, February 28, 2006; 113(8): 1130 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts Genomics and Cardiac Arrhythmias J. Am. Coll. Cardiol., January 3, 2006; 47(1): 9 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Hamlin A Search to Predict Potential for Drug-Induced Cardiovascular Toxicity Toxicol Pathol, January 1, 2006; 34(1): 75 - 80. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Brugada, K. Hong, J. M. Cordeiro, and R. Dumaine Short QT syndrome Can. Med. Assoc. J., November 22, 2005; 173(11): 1349 - 1354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schulze-Bahr Short QT Syndrome or Andersen Syndrome: Yin and Yang of Kir2.1 Channel Dysfunction Circ. Res., April 15, 2005; 96(7): 703 - 704. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Weiss, G. Seemann, F. B. Sachse, and O. Dössel Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall Europace, January 1, 2005; 7(s2): S105 - S117. [Abstract] [Full Text] [PDF]
|
|